Drug-drug interactions in the elderly;Interactions médicamenteuses chez le sujet âgé

Angeiologie

Volumn 52, Issue 5, 2000, Pages 25-38

  Tribut, O ^a   Reymann, J M ^a   Polard, E ^a   Allain, H ^a   Bentue Ferrer, D ^a  

^a Inst de Rech Contre le Cancer IRCC   (France)

Author keywords

Drug drug interactions; Elderly; Pharmacology; Pharmacovigilance

Indexed keywords

ALLOPURINOL; AMIODARONE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CABERGOLINE; CYTOCHROME P450; DIGITALIS; DIURETIC AGENT; GLUCOCORTICOID; IMIPRAMINE; ISONIAZID; LAXATIVE; LEVODOPA; LISURIDE; MOCLOBEMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ROPINIROLE; SALICYLIC ACID DERIVATIVE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; UNINDEXED DRUG;

AGED; ARTICLE; BLEEDING; CARDIOTOXICITY; CLINICAL TRIAL; CONVULSION; DRUG ANTAGONISM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENTIATION; HUMAN; HYPOGLYCEMIA; LIVER TOXICITY; NEPHROTOXICITY; OTOTOXICITY; POLYPHARMACY; SEROTONIN SYNDROME; ULCER;

EID: 0034494278     PISSN: 00033049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations
2. Important drug-interactions in the elderly
3. Les facteurs de variation de l'activité des médicaments
4. Clinical trials in the elderly. Should we do more?
5. Are the elderly underrepresented in clinical drug trials?
6. Le volontaire sain âgé : Une nécessité
7. Drug interactions in the elderly. How multiple drug use increases risk exponentially
8. Polypharmacy in the aged. Practical solutions
9. Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study
10. Potential drugdrug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden
11. Drug combinations and potential for risk of adverse drug reaction among community-dwelling elderly
12. Contribution of adverse drug reactions to hospital admission of older patients
13. Drug-drug interactions related to hospital admissions in older adults : A prospective study of 1000 patients
14. Les interactions médicamenteuses
15. Drug interactions in the elderly
16. Drug interactions in the older patients
17. Drug interactions in the elderly
18. Clinicaly significant drug interactions
19. Metabolism, bioavailability, and drug interactions
20. Cardiovascular pharmacology of aging
21. Risk factors in geriatric drug prescribing. A practical guide to avoiding problems
22. Pharmacokinetics in old age
23. Drug Interactions
24. Adverse drug reactions. An overview of special considerations in the management of the elderly patient
25. Polypathologies du sujet âgé et réponses thérapeutiques : Les pièges à éviter
26. Effets indésirables des médicaments chez la personne âgée : Une analyse de la Banque Nationale de cas en pharmacovigilance
27. Les effets indésirables des médicaments chez le sujet âgé : Épidémiologie et prévention
28. Interactions médicamenteuses
29. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old
30. Risk for serious gastrointestinal complications related to use of nonsteroïdal anti-inflammatory drugs: A meta-analysis
31. Causes of hospitalization of nursing home residents : The role of infection
32. Advances in the management of digoxin toxicity in the older patient
33. Epidemiology of adverse drug reactions in the elderly by drug class
34. Aging and the anticoagulant response to warfarin therapy
35. Epidemiology and drug treatment of epilepsy in elderly people
36. Electronic prescribing for the elderly. Will it improve medication usage?
37. Pharmacokinetic optimisation of drug therapy in elderly patients
38. Prescribing habits and potential adverse drug reactions in geriatric medicine
39. Prescriptions, adverse reactions and the elderly
40. Principles of drug therapy in geriatric patients